Catherine Alix-Panabières: Liquid Biopsy and the critical role of AI in the Early Detection of Pancreatic Cancer
Catherine Alix-Panabières, Professor of Oncology at the Faculty of Medicine of the University of Montpellier, shared a post on LinkedIn:
“I had the pleasure of being interviewed by Michael Eisenstein to discuss Liquid Biopsy and the critical role of AI in the Early Detection of Pancreatic Cancer.
Grateful for the opportunity to share insights on this exciting and rapidly evolving field!
During the interview, I had the chance to present our National PANLIPSY Project, supported by ARC Foundation for Cancer Research as well as PANCAID at the European level.
Our goal: to detect very early-stage pancreatic cancer through liquid biopsy — a simple, non-invasive blood test that captures circulating biomarkers originating not only from tumor cells (e.g., CTCs, ctDNA, EVs, Proteins, Nucleosomes) but also from the host environment (such as Immune Cells or Circulating Microbiota).
By harnessing the power of AI, we aim to develop precise algorithms capable of identifying which individuals may be developing pancreatic cancer — even before symptoms appear.
Enjoy reading this new article, published in the prestigious journal Nature!”
More posts featuring Catherine Alix-Panabières.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023